Mexico Judicial Reforms Spark Investor Concern

Mexico Judicial Reforms Spark Investor Concern

Our Chief Latin American Equity Strategist explains how potential changes in Mexico’s regulatory approach could have implications for the country’s equity markets.


----- Transcript -----


Welcome to Thoughts on the Market. I’m Nikolaj Lippmann, Morgan Stanley’s Chief Latin American Equity Strategist. Today I’ll talk about Mexico’s recent judicial reform and its potential impact on equities market.

It’s Friday, September 20, at 10am in Mexico City.

Mexico has made significant changes to its judicial system. After winning two-thirds majority in both houses – enough to allow for constitutional changes – Mexico policymakers have embarked on a robust reform agenda. Their first stop is a comprehensive reform of the judicial branch, which aims at replacing roughly 2,000 senior judges including the entire Supreme Court.

New judges will no longer be appointed but will now be elected by popular vote. This is practically unprecedented in a global context, and while the executive branch might still try to filter future candidates, this new system will likely create a real risk to checks and balances on the judicial branch as well as to expertise and procedure. Additional reforms, including the elimination of independent regulatory bodies, would likely compound these risks.

The judicial reform could have a material impact on Mexican equities. So much so, that we think Mexico goes from being an investor favorite to a ‘show me’ story where investors are less likely to give the market the benefit of the doubt. This is likely to result in a derailing or lower set of multiples being paid by investors in Mexican equities or higher risk premium required to invest.

Essentially, the judicial reforms could add fiscal, labor and concession/regulatory risk for Mexican companies, even though Mexico has deep manufacturing ecosystems, and has been well-positioned from the transition to [a] multipolar world. Just to give you a sense. Mexico has already sailed past China in terms of manufacturing exports to the United States, and are now approaching the levels of the entire European Union in terms of manufacturing export to the US.

These new reforms will raise significant investor concerns, so much so that we’ve downgraded Mexican equities to underweight, a second downgrade since June. Mexican equities have sold off roughly 20 per cent in the past three months, in dollar terms. And we think the judicial reform may contribute to further decline. All in, we see significantly greater potential for negative outcomes than positive outcomes going forward.

Looking ahead, we see three key challenges for Mexico:

First, the new judicial structure would raise concerns about the independence of the judicial branch.

Second, the United States-Mexico-Canada Agreement, the USMCA, is up for review in 2026, and Mexico's judicial reform could mean a much deeper revision. Mexico has committed to maintaining independent regulatory bodies for a number of areas, such as telecom, electricity, in competition. The judicial reform could complicate this commitment.

Electricity is a key challenge for Mexico, and it requires immediate investments. Our nearshoring investment thesis stands, but the electricity-related challenges are becoming more pronounced, and they won’t be helped by investor concerns around the judicial reform.

So all in, some businesses will be at greater risk from these developments. We expect technology, digitalization, real estate companies to be at the least level of risk, or the lowest level of risk. Domestic concessions could be at more risk.

We will continue to bring you relevant updates as Mexico reforms unfold.

Thank you for listening. If you enjoy Thoughts on the Market, please take a moment to rate and review us wherever you listen. It helps more people find the show.

Jaksot(1515)

Mike Wilson: A November to Remember

Mike Wilson: A November to Remember

Markets have spent November celebrating upbeat vaccine news and closure on U.S. election uncertainty. After a strong month, are equities headed for another reset?

30 Marras 20202min

Andrew Sheets: Are Emerging Markets Reemerging?

Andrew Sheets: Are Emerging Markets Reemerging?

Emerging market assets are poised to redeem some of their historic underperformance in 2021, but not all assets and indices in the class are equally positioned to take advantage of the cyclical upturn. Chief Cross-Asset Strategist Andrew Sheets explains.

27 Marras 20203min

Michael Zezas: The Real Risk of Fed/Treasury Conflict

Michael Zezas: The Real Risk of Fed/Treasury Conflict

A rare open disagreement between the Fed and the Treasury may have policy implications in the longer term. Michael Zezas, Head of U.S. Public Policy Research, explains.

25 Marras 20202min

U.S. Outlook 2021: Momentum Toward Recovery

U.S. Outlook 2021: Momentum Toward Recovery

Although the U.S. faces a challenging winter, vaccine availability and momentum could propel the economy to expand an impressive 6% in 2021. The forecast for investors.

24 Marras 202014min

Mike Wilson: Giving Thanks for a Brighter 2021

Mike Wilson: Giving Thanks for a Brighter 2021

As Thanksgiving approaches in the U.S., it’s worth taking a moment to be thankful for potential vaccines, a remarkably resilient economy and the strength of the human spirit.

23 Marras 20203min

Special Episode: 2021 Global Outlook

Special Episode: 2021 Global Outlook

Global economies are set for next phase of a V-shaped recovery in both developed and emerging markets. Why that could be good news for equities and credit markets.

21 Marras 202015min

Michael Zezas: Will D.C. Rein In Big Tech?

Michael Zezas: Will D.C. Rein In Big Tech?

Washington D.C. has become increasingly interested in tech regulation, but what’s the likelihood in the next two years? And what could it mean for tech stocks?

18 Marras 20202min

Mike Wilson: 2021 Preview - A Bull with Room to Run

Mike Wilson: 2021 Preview - A Bull with Room to Run

Although near-term worries about the coronavirus and higher interest rates could challenge company valuations, the 12-month U.S. equities outlook may be just what the doctor ordered.

16 Marras 20203min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-rahamania
herrasmieshakkerit
ostan-asuntoja-podcast
pari-sanaa-lastensuojelusta
rss-lahtijat
oppimisen-psykologia
lakicast
taloudellinen-mielenrauha
rss-neuvottelija-sami-miettinen
yrittaja
rss-startup-ministerio
rss-myynti-ei-ole-kirosana
hyva-paha-johtaminen
rss-myyntikoulu
rss-karon-grilli
rss-seuraava-potilas